Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma
- PMID: 22307917
- DOI: 10.1002/hep.25639
Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma
Comment on
-
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy.Hepatology. 2011 Dec;54(6):2055-63. doi: 10.1002/hep.24644. Hepatology. 2011. PMID: 21898496
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical